PL370500A1 - Doustna postać aplikacyjna dla środków spożywczych oraz uzupełniających środków spożywczych i środki dietetyczne - Google Patents

Doustna postać aplikacyjna dla środków spożywczych oraz uzupełniających środków spożywczych i środki dietetyczne

Info

Publication number: PL370500A1
Authority: PL; Poland
Prior art keywords: foodstuffs; supplementing; well; orally administered; administered form
Prior art date: 2003-11-06

Application number

PL04370500A

Other languages

English (en)

Other versions

PL207036B1 (pl

Inventor

Friedel Frauendorfer

Original Assignee

Meduna Arzneimittel Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-06

Filing date

2004-10-05

Publication date

2005-05-16

2004-10-05 Application filed by Meduna Arzneimittel Gmbh filed Critical Meduna Arzneimittel Gmbh

2005-05-16 Publication of PL370500A1 publication Critical patent/PL370500A1/pl

2010-10-29 Publication of PL207036B1 publication Critical patent/PL207036B1/pl

Links

230000001502 supplementing effect Effects 0.000 title 1
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 2
235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
230000003474 anti-emetic effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000001754 anti-pyretic effect Effects 0.000 abstract 1
239000002111 antiemetic agent Substances 0.000 abstract 1
239000002221 antipyretic Substances 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
229940090949 docosahexaenoic acid Drugs 0.000 abstract 1
235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000007903 gelatin capsule Substances 0.000 abstract 1
229960004488 linolenic acid Drugs 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
229940057917 medium chain triglycerides Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
239000006186 oral dosage form Substances 0.000 abstract 1
239000000047 product Substances 0.000 abstract 1
235000019155 vitamin A Nutrition 0.000 abstract 1
239000011719 vitamin A Substances 0.000 abstract 1
235000019166 vitamin D Nutrition 0.000 abstract 1
239000011710 vitamin D Substances 0.000 abstract 1
235000019165 vitamin E Nutrition 0.000 abstract 1
239000011709 vitamin E Substances 0.000 abstract 1
235000019168 vitamin K Nutrition 0.000 abstract 1
239000011712 vitamin K Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL370500A 2003-11-06 2004-10-05 Doustna postać aplikacyjna dla środków spożywczych, uzupełniających środków spożywczych oraz środków dietetycznych PL207036B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03025259A EP1529524B1 (de)	2003-11-06	2003-11-06	Gelatinekapsel mit fettlöslichen Vitaminen und essentiellen Fettsäuren

Publications (2)

Publication Number	Publication Date
PL370500A1 true PL370500A1 (pl)	2005-05-16
PL207036B1 PL207036B1 (pl)	2010-10-29

Family

ID=34429263

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL370500A PL207036B1 (pl)	2003-11-06	2004-10-05	Doustna postać aplikacyjna dla środków spożywczych, uzupełniających środków spożywczych oraz środków dietetycznych

Country Status (6)

Country	Link
EP (1)	EP1529524B1 (pl)
AT (1)	ATE316783T1 (pl)
DE (1)	DE50302327D1 (pl)
ES (1)	ES2255653T3 (pl)
NO (1)	NO20044856L (pl)
PL (1)	PL207036B1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5628480B2 (ja)	2006-03-09	2014-11-19	グラクソスミスクラインエルエルシー	医薬成分を含有するコーティングカプセル
US8784886B2 (en)	2006-03-09	2014-07-22	GlaxoSmithKline, LLC	Coating capsules with active pharmaceutical ingredients
EP3586640A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586642A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Ala enriched polyunsaturated fatty acid compositions
EP3586643A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586641A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
US20220047611A1 (en) *	2018-09-11	2022-02-17	Parapharm Development Limited	Capsule, Tablet or Pill

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4304394A1 (en) *	1993-02-13	1993-09-02	Fresenius Ag	Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
DE4405545A1 (de) *	1994-02-22	1995-08-31	Dietl Hans	Fettlösliche Vitamine enthaltende Zubereitung zur oralen Applikation
DE19930030B4 (de) *	1999-06-30	2004-02-19	Meduna Arzneimittel Gmbh	CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform
US6511696B2 (en) *	2000-12-13	2003-01-28	Novartis Nutrition Ag	Infant formula with free amino acids and nucleotides

2003
- 2003-11-06 AT AT03025259T patent/ATE316783T1/de active
- 2003-11-06 EP EP03025259A patent/EP1529524B1/de not_active Expired - Lifetime
- 2003-11-06 DE DE50302327T patent/DE50302327D1/de not_active Expired - Lifetime
- 2003-11-06 ES ES03025259T patent/ES2255653T3/es not_active Expired - Lifetime
2004
- 2004-10-05 PL PL370500A patent/PL207036B1/pl unknown
- 2004-11-08 NO NO20044856A patent/NO20044856L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE50302327D1 (de)	2006-04-13
NO20044856L (no)	2005-05-09
ES2255653T3 (es)	2006-07-01
ATE316783T1 (de)	2006-02-15
EP1529524B1 (de)	2006-02-01
EP1529524A1 (de)	2005-05-11
PL207036B1 (pl)	2010-10-29

Publication	Publication Date	Title
Seaman	2002	The diet-induced proinflammatory state
US6630158B2 (en)	2003-10-07	Dietary supplement composition and method for improving and maintaining healthy skin
AU2004266043B2 (en)	2007-09-20	Micronutrient supplement
CA2747753C (en)	2015-03-17	Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health
Houston	2007	Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals
PL370500A1 (pl)	2005-05-16	Doustna postać aplikacyjna dla środków spożywczych oraz uzupełniających środków spożywczych i środki dietetyczne
O'Connor	2014	An overview of the role of diet in the treatment of rheumatoid arthritis
US20130064924A1 (en)	2013-03-14	Nutritional supplement for use under physiologically stressful conditions
Thompson	2006	Vitamins and minerals 4: overview of folate and the B vitamins
Nair	2001	Alternate strategies for improving iron nutrition: lessons from recent research
WO2005074702A1 (fr)	2005-08-18	Preparation de gomme comprenant des vitamines, des elements nutritifs anti-oxydants et des oligo-elements
Badsha et al.	2022	Nutritional supplements in health care
WO2002043662A3 (en)	2003-01-23	Dietary composition containing conjugated linoleic acid and calcium for improved health
Pal et al.	2025	Role of Micronutrients in Obesity and Weight Management
CA2478278C (en)	2011-08-02	Micronutrient supplement
Proudman	2011	Omega-3 fatty acids for early rheumatoid arthritis
Simons	2013	The Components of Life: All about Vitamins, Minerals, Amino acids, Enzymes & Co.
Should et al.	0	SUPER OMEGA 3 FISH OIL 1000 mg-400 EPA/300 DHA-200 Softgels
Sizer et al.	2008	The Vitamins
Jensen	2002	The Failures of American Medicine: Why Americans Have Become Chronically Ill, and what Can be Done about it
Should et al.	0	FISH OIL 180 EPA/120 DHA-200 Softgels
Wober	2003	Calcium supplements
Roe	1989	Nutrients as Supplements, Drugs, and Nostrums
Gonzalez	0	4 Supplements Every Human Needs And How to Pick the Healthiest One!
February	0	Pcos Supplements For Weight Loss